| Previous Close | 7.65 |
| Open | 7.72 |
| Bid | 6.50 x N/A |
| Ask | 8.95 x N/A |
| Day's Range | 7.33 - 8.20 |
| 52 Week Range | 4.00 - 11.34 |
| Volume | 1,430 |
| Avg. Volume | 475 |
| Market Cap | 237.87M |
| Beta (5Y Monthly) | 1.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.04 |
| Earnings Date | Dec. 15, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.41 |
- CNW Group
ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer
HOUSTON and VANCOUVER, BC, Jan. 13, 2021 /CNW/ - ESSA Pharma Inc.
- CNW Group
Media Advisory - Aviation Expert Lawyer Rod Winsor Available to Answer Compensation Questions for Families of Ukraine International Airline Victims
TORONTO, Jan. 8, 2021 /CNW/ -Â 1Â Year Anniversary, Ukraine International Airline Flight 752 Crash.
- CNW Group
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020
VANCOUVER and HOUSTON, Dec. 15, 2020 /CNW/ -Â ESSA Pharma Inc.
© 2021 Verizon Media. All rights reserved.
